HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M)
Clinical trials for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M) trials appear
Sign up with your email to follow new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with relapsed cancers: targeted drug trial opens
Disease control Recruiting nowThis study tests a new drug called Becotatug Vedotin in children aged 2 to 18 with certain cancers (like head and neck, brain, or kidney tumors) that have come back or spread. The drug targets a protein called EGFR found on many cancer cells. The main goal is to see if the drug i…
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M)
Phase: PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New drug combo aims to spare voice box in advanced throat cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy can help control advanced laryngeal or hypopharyngeal cancer while avoiding removal of the voice box (laryngectomy). About 87 adults with stage III-IV disease that is surgically removable …
Matched conditions: HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) - RECURRENT/METASTATIC (R/M)
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated May 14, 2026 12:03 UTC